Reproduction  
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  

Reproduction (2004) 128 259-267
DOI: 10.1530/rep.1.00243
Copyright © 2004 Society for Reproduction and Fertility
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in Reproduction
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stojkovic, M.
Right arrow Articles by Murdoch, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stojkovic, M.
Right arrow Articles by Murdoch, A.

REVIEW

Derivation, growth and applications of human embryonic stem cells

Miodrag Stojkovic, Majlinda Lako, Tom Strachan and Alison Murdoch1

Institute of Human Genetics, University of Newcastle, Newcastle upon Tyne, NE1 3BZ, UK and 1 Newcastle Fertility Centre at Life, NHS, Newcastle upon Tyne, NE1 4EP, UK

Correspondence should be addressed to M Stojkovic; Email: miodrag.stojkovic{at}ncl.ac.uk

Human embryonic stem (hES) cells are pluripotent cells derived from the inner cell mass cells of blastocysts with the potential to maintain an undifferentiated state indefinitely. Fully characterised hES cell lines express typical stem cell markers, possess high levels of telomerase activity, show normal karyotype and have the potential to differentiate into numerous cell types under in vitro and in vivo conditions. Therefore, hES cells are potentially valuable for the development of cell transplantation therapies for the treatment of various human diseases. However, there are a number of factors which may limit the medical application of hES cells: (a) continuous culture of hES cells in an undifferentiated state requires the presence of feeder layers and animal-based ingredients which incurs a risk of cross-transfer of pathogens; (b) hES cells demonstrate high genomic instability and non-predictable differentiation after long-term growth; and (c) differentiated hES cells express molecules which could cause immune rejection. In this review we summarise recent progress in the derivation and growth of undifferentiated hES cells and their differentiated progeny, and the problems associated with these techniques. We also examine the potential use of the therapeutic cloning technique to derive isogenic hES cells.


Related articles in Reproduction:

Focus on ART
Daniel R Brison
Reproduction 2004 128: 257-258. [Full Text]  



This article has been cited by other articles:


Home page
Hum ReprodHome page
T. Muller, G. Fleischmann, K. Eildermann, K. Matz-Rensing, P. A. Horn, E. Sasaki, and R. Behr
A novel embryonic stem cell line derived from the common marmoset monkey (Callithrix jacchus) exhibiting germ cell-like characteristics
Hum. Reprod., June 1, 2009; 24(6): 1359 - 1372.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
M. Bhatia
Hematopoietic Development from Human Embryonic Stem Cells
Hematology, January 1, 2007; 2007(1): 11 - 16.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Trounson
The Production and Directed Differentiation of Human Embryonic Stem Cells
Endocr. Rev., April 1, 2006; 27(2): 208 - 219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  
Copyright © 2004 by the Society for Reproduction and Fertility.